Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management Dysgeusia (taste disturbance) is not listed in the UK Summary of Product Characteristics for Ozempic Potential contributing factors include gastrointestinal side effects, dehydration, concurrent medications, vitamin B12 deficiency, or oral health issues Management includes good oral hygiene, dietary modifications, staying hydrated, and reviewing concurrent medications with your healthcare provider Contact your GP if metallic taste persists beyond 23 weeks, affects nutritional intake, or accompanies other concerning symptoms Alternative diabetes medications include other GLP-1 agonists, SGLT2 inhibitors, DPP-4 inhibitors, or insulin therapy as recommended by NICE guidance Table of Contents What Causes Metallic Taste When Taking Ozempic
If needed, the next steps may include additional medications that enhance the effects of first-choice drugs (known as combination therapy)
The choice here is critical, and we'll dive deeper into it in the next section
In research settings, this is associated with: Reduced hedonic feeding behavior Reduced impulsive food-seeking activity Reduced food noiselike behavioral patterns For many research subjects , these effects are desirable within the scope of metabolic and obesity-related studies